Rennova Health, Inc.
RNVA
RNVA was delisted on the 24th of October, 2017.
12 hedge funds and large institutions have $761K invested in Rennova Health, Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
279% more capital invested
Capital invested by funds: $201K → $761K (+$560K)
33% more funds holding
Funds holding: 9 → 12 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$795K |
| 2 |
Renaissance Technologies
New York
|
+$183K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$99K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$47.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$111K |
RNVA Hedge Fund Activity: Q3 2016 in Review
12 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q3 2016, worth a combined $761K — up 279% from $201K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RNVA positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $795K. The largest seller was Deerfield Management, exiting entirely with an estimated $111K sold.
- 12 institutional investors held Rennova Health, Inc. (RNVA) as of Q3 2016, up from 9 in Q2 2016.
- Funds reported $761K of Rennova Health, Inc. stock for Q3 2016, up 279% quarter-over-quarter.
- 4 funds opened new Rennova Health, Inc. positions in Q3 2016 and 1 closed out, a net change of +3 holders.
- The largest Rennova Health, Inc. buyer in Q3 2016 was Sabby Management, an estimated $795K added.
- The largest Rennova Health, Inc. seller in Q3 2016 was Deerfield Management, an estimated $111K sold.
Based on aggregated 13F filings for Q3 2016.